<PAGE>



                                                                   EXHIBIT 10.15

                   THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT
                      AND HAS NOT BEEN REGISTERED UNDER THE
                    SECURITIES ACT OF 1933 OR THE SECURITIES
                     LAWS OF ANY STATE. THIS NOTE MAY NOT BE
                   SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH
                      REGISTRATION OR AN OPINION OF COUNSEL
                      SATISFACTORY TO THE ISSUER THAT SUCH
                    REGISTRATION IS NOT REQUIRED BY SAID ACT
                                 OR STATE LAWS,


                                ORTHOMETRIX, INC.


$40,000.00                                                White Plains, New York
                                                              September 12, 2003


         ORTHOMETRIX, INC., a Delaware corporation (the "Company"), for value
received, promises to pay to REYNALD BONMATI (the "Payee"), the principal sum of
Forty Thousand U.S. Dollars ($40,000) on September 12, 2004 (the "Maturity
Date"), except as otherwise provided herein, together with interest on the
outstanding principal amount of this Note at the rate of prime (as published
from time to time by JP Morgan Chase) plus one per annum, except as otherwise
provided herein. Interest shall be payable quarterly on the last business day of
each March, June, September and December, commencing September 30, 2003.

         1. Payments and Prepayments.

         1.1 Payments and prepayments of principal and interest on this Note
shall be made to Payee at 106 Corporate Park Drive, Suite 102, White Plains,
N.Y. 10604.

         1.2 Payments and prepayments of principal and interest on this Note
shall be made in lawful money of the United States of America.

         1.3 If any payment on this Note becomes due and payable on a Saturday,
Sunday or other day an which commercial banks in New York City are authorized or
required by law to close, the maturity thereof shall be extended to the next
succeeding business day, and, with respect to payments of principal, interest
thereon shall be payable during such extension at the then applicable rate.

         1.4 The Company shall be obligated to prepay the outstanding principal
amount of this Note within ten (10) days after such time as (i) the Company
receives the Release Payment due on or before January 31, 2004 from
CooperSurgical, Inc. under the Asset Purchase Agreement dated as

<PAGE>

of February 27, 2002, or(ii) the Company receives net proceeds of at least
$1,000,000 from an equity financing, or (iii) the Company sells substantially
all its assets. The Company shall have the right at any time and from time to
time to prepay this Note in whole or in part, together with interest on the
amount prepaid to the date of prepayment, without penalty or premium. Upon
payment of part of the principal amount of this Note, the Company may require
the holder to present this Note for notation of such payment and, if this Note
is paid in full, require the holder to surrender this Note.

         1.5 Upon payment in full of all outstanding principal and interest due
under this Note, the Company's obligations in respect of payment of this Note
shall terminate and the holder shall return it to the Company.

         2. Events of Default. In the event that:

            (a) the Company defaults for more than five business days in making
any payment required to be made on this Note; or

            (b) the Company hereafter makes an assignment for the benefit of
creditors, or files a petition in bankruptcy as to itself, is adjudicated
insolvent or bankrupt, petitions or applies to any tribunal for the appointment
of any receiver of or any trustee for the Company or any substantial part of its
property under any bankruptcy, reorganization, arrangement, readjustment of
debt, dissolution or liquidation law or statute of any jurisdiction, whether now
or hereafter in effect; or if there is hereafter commenced against the Company
any such proceeding and an order approving the petition is entered or such
proceeding remains undismissed for a period of 60 day, or the Company or its
general partner by any act or omission to act indicates its consent to or
approval of or acquiescence in any such proceeding or the appointment of any
receiver of, or trustee for, the Company or any substantial part of its
property, or suffers any such receivership or trusteeship to continue
undischarged for a period of 60 days;

         then, and in any such event, and at any time thereafter, if such event
shall then be continuing, the holder of this Note may, by written notice to the
Company, declare the Note due and payable, whereupon the same shall be due and
payable without presentment, demand, protest or other notice of any kind, all of
which are hereby expressly waived.

         3. Investment Representation.

         3.1 The Payee hereby acknowledges that the Note is not being registered
(i) under the Securities Act of 1933, as amended (the "Act"), on the ground that
the issuance of the Note is exempt from registration under Section 4(2) of the
Act as not involving any public offering or (ii) under any applicable state
securities law because the issuance of the Note does not involve any public
offering; and that the Company's reliance on the Section 4(2) exemption of the
Act and under applicable state securities laws is predicated in part on the
representations hereby made to the Company by the Payee that it is acquiring the
Note for investment for its own account, with no present intention of dividing
its participation with others or reselling or otherwise distributing the same,
subject, nevertheless, to any requirement of law that the disposition of its
property shall at all times be within its control.


<PAGE>

         3.2 The Payee hereby agrees that it will not sell or transfer all or
any part of this Note unless and until it shall first have given notice to the
Company describing such sale or transfer and furnished to the Company an
opinion, reasonably satisfactory to counsel for the Company, of counsel skilled
in securities matters (selected by the holder and reasonably satisfactory to the
Company) to the effect that the proposed sale or transfer may be made without
registration under the Act and without registration or qualification under any
state.

         3.3 The Company may refuse to recognize a transfer of this Note on its
books should a holder attempt to transfer this Note otherwise than in compliance
with this Section 3.

         4. Miscellaneous.

         4.1 Upon receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of this Note and of a letter of
indemnity reasonably satisfactory to the Company, and upon reimbursement to the
Company of all reasonable expenses incident thereto, and upon surrender or
cancellation of the Note, if mutilated, the Company will make and deliver a new
Note of like tenor in lieu of such lost, stolen, destroyed or mutilated Note.

         4.2 This Note and the rights and obligations of the Company and each
holder hereunder shall be construed in accordance with and be governed by the
laws of the State of New York.

         IN WITNESS WHEREOF, the Company has executed this Note as of the day
and year first above written.

                                              ORTHOMETRIX, INC,



                                              By: /s/ Neil Koenig
                                                  -----------------------------
                                                  Name:  Neil Koenig
                                                  Title: Chief Financial Office